Skip to main content
Clinical Trials/NCT05618990
NCT05618990
Recruiting
Not Applicable

OPTIMIZATION of AVANCED MR SEQUENCES for BRAIN STUDIES in VOLUNTEERS (HEALTHY and PATIENTS)

Centre Hospitalier St Anne1 site in 1 country300 target enrollmentNovember 5, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Neurosciences
Sponsor
Centre Hospitalier St Anne
Enrollment
300
Locations
1
Primary Endpoint
MR sequences optimization
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

This monocentric methodological study aims at optimizing advanced MR sequences for image quality (reduced artefacts, signal to noise ratio, acquisition time, stability of quantitative measurements) on a new MR unit dedicated to research in clinical and cognitive neuroscience.

Detailed Description

Primary goal : Optimization of MR protocols and validation of acquisition parameters of advanced MR sequences on healthy volunteers or patients on a new 3T MR unit dedicated to research in neurosciences. Secondary goals 1. Perform acquisitions to validate the feasibility of research MR protocols (pilot subjects) 2. reproducibility studies

Registry
clinicaltrials.gov
Start Date
November 5, 2019
End Date
December 5, 2025
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Centre Hospitalier St Anne
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Covered by social security
  • For women in age of procreation, under efficient contraception
  • Written consent

Exclusion Criteria

  • Any MR contraindication
  • Claustrophobia
  • Pregnancy
  • Under judiciary protection

Outcomes

Primary Outcomes

MR sequences optimization

Time Frame: 72 months

Optimization of MR protocols and validation of acquisition parameters of advanced MR sequences on healthy volunteers or patients on a new 3T MR unit dedicated to research in neurosciences. Outcome measures depend on each pulse optimized sequence (signal-to-noise ratio, contrast-to-noise ratio, quantitative MR biomarkers).

Secondary Outcomes

  • Reproducibility studies(72 months)
  • Pilot studies(72 months)

Study Sites (1)

Loading locations...

Similar Trials